Congenital Heart Disease
Congenital heart disease (CHD) is a problem present at birth that involves the structure of the heart, its valves, or blood vessels. It is the most common type of birth defect, affecting about one in 100 babies. There are many types of congenital heart disease; some are mild, showing no signs or symptoms and often are not diagnosed until later in life. Others are more complex and require special medical or surgical treatment shortly after birth and lifelong care or monitoring. Thanks to medical advances, increasing numbers of children with CHD are surviving into adulthood, at which time their condition is known as adult congenital heart disease (ACHD).
UAB Medicine operates a Marfan Syndrome and Related Disorders Clinic, which is a multi-specialty clinic that includes physicians from the UAB Department of Pediatric Cardiology and the UAB Department of Genetics. Services offered include physical exams, echocardiogram/EKG, and genetic testing for diseases and conditions of the aorta, when needed. The clinic’s genetic counselor works with patients to help them better understand their condition and evaluate their risk for medical issues based on genetic testing results.
Because Marfan syndrome can affect the heart, patient care also may be provided by the UAB Congenital Heart Disease Program. The program offers the most advanced care for congenital (present at birth) heart disease, which often requires lifetime monitoring and care. Our multi-specialty team of pediatric and adult cardiologists, cardiovascular surgeons, cardiovascular anesthesiologists, and maternal-fetal medicine specialists have unique expertise in treating patients before birth and into adulthood.
UAB Medicine’s modern ultrasound equipment allows many heart defects to be diagnosed before a child is born. Screening exams performed at 18-20 weeks are recommended for expecting mothers or fathers known to have congenital heart disease. If a defect is discovered, our experts provide prenatal treatment and develop a plan for delivery and treatment after birth.
Thanks to advances in pediatric congenital care, the life expectancy for most patients now reaches far into adulthood. However, more than half of the people with congenital heart problems stop seeing a cardiologist once they turn 18. UAB’s Alabama Adult Congenital Heart Disease Program is designed to prevent that gap in care. As the only adult congenital heart disease program in the state and one of only a few in the country, our expertise greatly increases the chances that symptoms will be identified early. This helps ensure that less serious problems are addressed before they develop into larger, more life-threatening issues such as heart failure, arrhythmia, residual congenital heart defects, endocarditis, and stroke.
Dr. Cribbs on Business Break
Zaidan's Story: Hypoplastic Left Heart Syndrome/Heart Transplant
More than 20,000 adults enter the Adult Congenital Heart Disease population every year, but 60% are lost to follow-up care.
Care of Adults with Congenital Heart Disease
Fetal Cardiac Services at UAB Medicine
Drs. Joseph R. Biggio and Robb L. Romp discuss how the UAB Fetal Diagnosis and Care Center brings together experts at UAB Medicine and Children's of Alabama Joseph S. Bruno Pediatric Heart Center to care for high risk moms and babies from the moment a congenital abnormality is suspected.
Individuals born with congenital heart disease are now thriving into adulthood, but need lifelong follow-up care from sub-specialty experts.
Adult Congenital Heart Disease Risk Factors, Symptoms & Treatments
Some people are born with a defect or malformation in their heart or blood vessels, and this is called Congenital Heart Disease. UAB Cardiologist Edward Colvin, MD, talks to Daytime Alabama on WVTM-TV, Channel 13, in Birmingham, Ala., about the types of congenital heart disease and what adults with this disease should look for when choosing a doctor.
UAB is an active participant in research and clinical trials for congenital heart disease. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.View Clinical Trials
Joint Commission awards ventricular device certification to UAB Cardiovascular Institute
UAB receives GOLD certification for cardio-oncology program from International Society of Cardio-Oncology
A Silent Killer: How High Blood Pressure Hurts the Body
Guinness World Records Names Longest Survivor of an Artificial Double Heart-Valve Replacement
UAB’s Cardiothoracic Surgery Unit has been Awarded the Beacon Award for Excellence by AACN